Adial Pharmaceuticals Inc
NASDAQ:ADIL

Watchlist Manager
Adial Pharmaceuticals Inc Logo
Adial Pharmaceuticals Inc
NASDAQ:ADIL
Watchlist
Price: 0.685 USD -0.44% Market Closed
Market Cap: 4.5m USD

Intrinsic Value

ADIL doesn't have a meaningful market cap.
ADIL's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one ADIL stock under the Base Case scenario is 0.485 USD. Compared to the current market price of 0.685 USD, Adial Pharmaceuticals Inc is Overvalued by 29%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ADIL Intrinsic Value
0.485 USD
Overvaluation 29%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Adial Pharmaceuticals Inc

Valuation History Unavailable

Historical valuation for ADIL cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Adial Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Adial Pharmaceuticals Inc

Current Assets 2.6m
Cash & Short-Term Investments 2.4m
Other Current Assets 263.4k
Non-Current Assets 821.9k
Long-Term Investments 818.7k
Intangibles 3.2k
Efficiency

Free Cash Flow Analysis
Adial Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Adial Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-8.7m USD
Operating Income
-8.7m USD
Other Expenses
-243k USD
Net Income
-8.9m USD
Fundamental Scores

ADIL Profitability Score
Profitability Due Diligence

Adial Pharmaceuticals Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

29/100
Profitability
Score

Adial Pharmaceuticals Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

ADIL Solvency Score
Solvency Due Diligence

Adial Pharmaceuticals Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
53/100
Solvency
Score

Adial Pharmaceuticals Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ADIL Price Targets Summary
Adial Pharmaceuticals Inc

There are no price targets for ADIL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Adial Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ADIL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ADIL Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ADIL stock?

The intrinsic value of one ADIL stock under the Base Case scenario is 0.485 USD.

Is ADIL stock undervalued or overvalued?

Compared to the current market price of 0.685 USD, Adial Pharmaceuticals Inc is Overvalued by 29%.

Back to Top